Adverum Biotechnologies, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Adverum Biotechnologies, Inc. reported Increase (Decrease) in Other Noncurrent Liabilities of $74.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2023-03-30
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-12-31 was $19.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-09-30 was $93.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-06-30 was -$57.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-03-31 was $19.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $74.00K.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $1.11M.
- Adverum Biotechnologies, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $112.00K derived: sum of 2 quarters · filed 2023-03-30 | $55.00K derived: sum of 3 quarters · filed 2023-03-30 | $74.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $36.00K derived: sum of 2 quarters · filed 2022-11-10 | $55.00K 10-Q · filed 2022-11-10 | $55.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$38.00K 10-Q · filed 2022-08-11 | -$38.00K derived: sum of 3 quarters · filed 2023-03-30 | -$38.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | $19.00K 10-Q · filed 2022-05-12 | $19.00K derived: sum of 2 quarters · filed 2023-03-30 | $19.00K derived: sum of 3 quarters · filed 2023-03-30 | $19.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $1.11M 10-K · filed 2022-03-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |